Latest On Windtree Therapeutics, Inc (WINT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-15 19:49 EST | News | Windtree TherapeuticS GAAP EPS of -$4.76 | N/A |  |
| 2023-04-20 17:58 EST | News | Windtree Therapeutics stock slides after pricing $10.8M equity offering | N/A | |
| 2023-04-03 16:19 EST | News | Windtree TherapeuticS GAAP EPS of -$13.01 | N/A | |
| 2023-03-14 00:16 EST | News | Windtree Therapeutics regains compliance with Nasdaq | N/A | |
| 2023-02-24 00:23 EST | News | Windtree Therapeutics announces 1-for-50 reverse stock split | N/A | |
| 2022-11-14 21:16 EST | News | Windtree TherapeuticS GAAP EPS of -$0.13 beats by $0.13 | N/A | |
| 2022-10-25 21:35 EST | News | Windtree receives US patent for istaroxime to treat acute heart failure | N/A | |
| 2022-08-11 21:45 EST | News | Windtree TherapeuticS GAAP EPS of -$0.59 | N/A | |
| 2022-05-05 19:28 EST | News | Windtree TherapeuticS GAAP EPS of -$0.29 beats by $0.01 | N/A | |
| 2022-04-20 08:45 EST | News | Windtree gains after early mid-stage results for istaroxime in cardiogenic shock | N/A | |
| 2022-04-01 01:27 EST | News | Windtree TherapeuticS GAAP EPS of -$2.73 misses by $0.17 | N/A | |
| 2022-02-01 21:28 EST | News | Windtree completes enrollment in phase 2 trial of lucinactant for COVID-19 lung injury | N/A | |
| 2021-12-06 09:46 EST | News | Windtree Therapeutics CEO Craig Fraser - Breaking Down Acute Heart Failure (Video) | N/A | |
| 2021-11-10 23:31 EST | News | Windtree TherapeuticS EPS misses by $0.02 | N/A | |
| 2021-11-03 06:28 EST | News | Warning: WINT is at high risk of performing badly | N/A | |
| 2021-08-05 20:24 EST | News | Windtree TherapeuticS EPS misses by $0.94 | N/A | |
| 2021-07-22 17:06 EST | News | Windtree Therapeutics: Addressing Underserved And Expensive Acute Conditions | N/A | |
| 2021-03-30 00:23 EST | News | Windtree TherapeuticS EPS beats by $0.01 | N/A | |
| 2021-03-23 17:48 EST | News | Windtree Therapeutics slumps on pricing $30M stock offering | N/A | |
| 2021-03-22 21:11 EST | News | Windtree Therapeutics under pressure on stock offering | N/A | |
| 2021-01-06 16:05 EST | News | Dosing underway in Windtree's mid-stage lucinactant COVID-19 trial | N/A | |
| 2020-12-04 06:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 07:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 06:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 05:08 EST | News | Windtree Therapeutics reports Q3 results | N/A | |
| 2020-11-17 14:53 EST | Earnings Estimate | An EPS average of -$0.41 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-10-30 10:47 EST | Insider Trade | Craig Fraser has directly acquired 250 shares and currently holds 24,298 shares. | Buy | |
| 2020-10-27 06:09 EST | Insider Trade | James Huang has directly acquired 1,000 shares and currently holds 21,000 shares. | Buy | |
| 2020-10-13 08:45 EST | Insider Trade | Craig Fraser has directly acquired 250 shares and currently holds 24,048 shares. | Buy | |
| 2020-10-09 08:26 EST | Insider Trade | Eric Curtis has directly acquired 500 shares and currently holds 500 shares. | Buy | |
| 2020-10-09 08:26 EST | Insider Trade | Craig Fraser has directly acquired 250 shares and currently holds 23,798 shares. | Buy | |
| 2020-10-09 08:26 EST | Insider Trade | John P. Hamill has directly acquired 1,000 shares and currently holds 1,000 shares. | Buy | |
| 2020-10-08 21:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-02 10:41 EST | News | Dosing underway in Windtree Therapeutics' mid-stage istaroxime study in heart disease | N/A | |
| 2020-09-29 20:08 EST | News | Windtree Therapeutics on go with mid-stage study for COVID-19 drug candidate | N/A | |
| 2020-09-26 16:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-03 11:23 EST | Analyst Rating | The Analyst Target Price has decreased from $12.25 to $12.13. | Neutral | |
| 2020-08-17 03:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-15 14:49 EST | News | Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin | N/A | |
| 2020-08-14 12:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:08 EST | News | Windtree Therapeutics reports Q2 results | N/A | |
| 2020-08-06 16:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:33 EST | Financials | Company financials have been released. | Neutral | |
About Windtree Therapeutics, Inc (WINT):
Windtree Therapeutics, Inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Its four lead development programs include istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as in Phase 2a clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase 2b clinical trial to treat respiratory distress syndrome (RDS) in premature infants; lyophilized KL4 surfactant for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania.
General
- Name Windtree Therapeutics, Inc
- Symbol WINT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 31
- Last Split Factor1:3
- Last Split Date2020-04-29
- Fiscal Year EndDecember
- IPO Date1995-08-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.windtreetx.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 660.53
- Price/Book (Most Recent Quarter) 0.91
- Enterprise Value Revenue 706.08
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.45
- Return on Assets -15%
- Return on Equity -50%
- Earnings Per Share -$2.13
- Revenue Per Share $0
- Gross Profit -12489000
- Quarterly Earnings Growth -100%
View More
Highlights
- Market Capitalization 67.01 million
- EBITDA -21255000
- Analyst Target Price $12.13
- Book Value Per Share $4.48
View More
Share Statistics
- Shares Outstanding 16.92 million
- Shares Float 4.47 million
- % Held by Insiders 7356%
- % Held by Institutions 4.35%
- Shares Short 86879
- Shares Short Prior Month 85445
- Short Ratio 2.09
- Short % of Float 1%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta -0.08
- 52 Week High $11.22
- 52 Week Low $3.6
- 50 Day Moving Average 4.98
- 200 Day Moving Average 5.92
View More
Dividends
- Dividend Date 2020-04-29
- ExDividend Date N/A
- Dividend Yield 0%
View More
Windtree Therapeutics, Inc (WINT) Dividend Calendar:
WINT's last dividend payment was made to shareholders on April 29, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Windtree Therapeutics, Inc (WINT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-16 | $N/A | -$0.54 | -$0.49 | -11.34% |
| 2020-06-30 | 2020-08-14 | $N/A | -$0.63 | -$0.36 | -75% |
| 2020-03-31 | 2020-05-13 | $N/A | -$0.48 | ||
| 2019-09-30 | 2019-11-14 | $N/A | -$0.22 | ||
| 2019-06-30 | 2019-08-14 | $158000 | -$0.20 | ||
| 2019-03-31 | 2019-04-16 | $40000 | -$0.20 | ||
| 2018-12-31 | 2019-03-14 | $304000 | -$9.71 | ||
| 2018-09-30 | 2018-11-14 | $229000 | -$3.13 | ||
| 2018-06-30 | 2018-08-14 | $1.05 million | -$2.44 | ||
| 2018-03-31 | 2018-04-17 | $204000 | -$4.19 | ||
| 2017-12-31 | 2018-03-15 | $102000 | $2.54 | ||
| 2017-09-30 | 2017-11-14 | $17000 | -$41.47 | ||
| 2017-06-30 | 2017-08-21 | $1.15 million | -$45.60 | -$59.40 | 23.23% |
| 2017-03-31 | 2017-05-15 | $219000 | -$82.20 | -$19.80 | -315.15% |
| 2016-12-31 | 2017-03-31 | $900000 | -$46.20 | -$15.60 | -196.15% |
| 2016-09-30 | 2016-11-14 | $961000 | -$60.00 | -$65.40 | 8.26% |
| 2016-06-30 | 2016-08-10 | $106000 | -$77.40 | -$98.10 | 21.1% |
| 2016-03-31 | 2016-05-12 | $150000 | -$102.00 | -$94.80 | -7.59% |
| 2015-12-31 | 2016-03-24 | $514000 | -$75.60 | -$42.00 | -80% |
| 2015-09-30 | 2015-11-05 | $132000 | -$1.26 | -$1.05 | -20% |
| 2015-06-30 | 2015-08-10 | $150000 | -$1.82 | -$1.82 | 0% |
| 2015-03-31 | 2015-05-07 | $191000 | -$1.96 | -$1.47 | -33.33% |
| 2014-12-31 | 2015-03-16 | $2.4 million | -$1.68 | -$2.01 | 16.42% |
| 2014-09-30 | 2014-11-06 | $1.05 million | -$1.82 | -$2.05 | 11.22% |
| 2014-06-30 | 2014-08-05 | $2.19 million | -$33.60 | -$40.60 | 17.24% |
| 2014-03-31 | 2014-05-08 | $62000 | -$39.20 | -$36.43 | -7.6% |
| 2013-12-31 | 2014-03-13 | $73000 | -$44.80 | -$44.89 | 0.2% |
| 2013-09-30 | 2013-11-12 | $61000 | -$61.60 | -$55.07 | -11.86% |
| 2013-06-30 | 2013-08-08 | $182000 | -$50.40 | -$77.37 | 34.86% |
| 2013-03-31 | 2013-05-07 | $72000 | -$81.20 | -$71.87 | -12.98% |
| 2012-12-31 | 2013-03-13 | $195000 | -$44.80 | -$77.47 | 42.17% |
| 2012-09-30 | 2012-11-08 | $N/A | -$86.80 | -$63.47 | -36.76% |
| 2012-06-30 | 2012-08-02 | $N/A | -$44.80 | -$58.80 | 23.81% |
| 2012-03-31 | 2012-05-03 | $N/A | -$103.60 | -$47.60 | -117.65% |
| 2011-12-31 | 2012-03-29 | $N/A | -$50.40 | -$50.40 | 0% |
| 2011-09-30 | 2011-11-10 | $N/A | -$56.00 | -$78.40 | 28.57% |
| 2011-06-30 | 2011-08-03 | $201000 | -$95.20 | -$84.00 | -13.33% |
| 2011-03-31 | 2011-05-05 | $381000 | -$58.80 | -$92.40 | 36.36% |
| 2010-12-31 | 2011-03-22 | $N/A | -$117.60 | -$128.80 | 8.7% |
| 2010-09-30 | 2010-11-09 | $N/A | -$126.00 | -$168.00 | 25% |
| 2010-06-30 | 2010-08-04 | $N/A | -$168.00 | -$168.00 | 0% |
| 2010-03-31 | 2010-05-10 | $N/A | -$666.84 | ||
| 2009-12-31 | 2010-03-10 | $N/A | -$615.83 | ||
| 2009-09-30 | 2009-11-04 | $N/A | -$252.00 | -$252.00 | 0% |
| 2009-06-30 | 2009-07-29 | $N/A | -$294.00 | -$378.00 | 22.22% |
| 2009-03-31 | 2009-04-28 | $N/A | -$378.00 | -$420.00 | 10% |
| 2008-12-31 | 2009-03-13 | $N/A | -$336.00 | -$462.00 | 27.27% |
| 2008-09-30 | 2008-11-04 | $50000 | -$462.00 | -$567.00 | 18.52% |
| 2008-06-30 | 2008-08-06 | $2.5 million | -$462.00 | -$472.50 | 2.22% |
| 2008-03-31 | 2008-05-06 | $2.05 million | -$420.00 | -$577.50 | 27.27% |
| 2007-12-31 | 2008-02-14 | $N/A | -$588.00 | -$493.50 | -19.15% |
| 2007-09-30 | 2007-11-06 | $N/A | -$462.00 | -$493.50 | 6.38% |
| 2007-06-30 | 2007-08-02 | $N/A | -$504.00 | -$462.00 | -9.09% |
| 2007-03-31 | 2007-05-02 | $N/A | -$504.00 | -$567.00 | 11.11% |
| 2006-12-31 | 2007-02-28 | $N/A | -$504.00 | -$529.20 | 4.76% |
| 2006-09-30 | 2006-11-08 | $N/A | -$546.00 | -$616.00 | 11.36% |
| 2006-06-30 | 2006-07-28 | $N/A | -$1,008.00 | -$1,026.00 | 1.75% |
| 2006-03-31 | 2006-05-09 | $N/A | -$966.00 | -$997.50 | 3.16% |
| 2005-12-31 | 2006-02-23 | $29000 | -$2,142.00 | -$924.00 | -131.82% |
| 2005-09-30 | 2005-11-03 | $20000 | -$798.00 | -$798.00 | 0% |
| 2005-06-30 | 2005-08-02 | $24000 | -$756.00 | -$784.00 | 3.57% |
| 2005-03-31 | 2005-04-27 | $61000 | -$756.00 | -$907.20 | 16.67% |
| 2004-12-31 | 2005-03-15 | $134000 | -$1,764.00 | -$1,167.60 | -51.08% |
| 2004-09-30 | 2004-11-04 | $236000 | -$756.00 | -$833.00 | 9.24% |
| 2004-06-30 | 2004-08-05 | $697000 | -$798.00 | -$840.00 | 5% |
| 2004-03-31 | 2004-05-06 | $142000 | -$840.00 | -$722.40 | -16.28% |
| 2003-12-31 | 2004-03-16 | $182000 | -$882.00 | -$672.00 | -31.25% |
| 2003-09-30 | 2003-11-13 | $198000 | -$630.00 | -$602.00 | -4.65% |
| 2003-06-30 | 2003-08-12 | $264000 | -$588.00 | -$588.00 | 0% |
| 2003-03-31 | 2003-05-14 | $393000 | -$588.00 | -$630.00 | 6.67% |
| 2002-12-31 | 2003-02-20 | $394000 | -$714.00 | -$714.00 | 0% |
| 2002-09-30 | 2002-11-08 | $368000 | -$714.00 | -$693.00 | -3.03% |
| 2002-06-30 | 2002-08-05 | $783000 | -$672.00 | -$672.00 | 0% |
| 2002-03-31 | 2002-05-29 | $237000 | -$1,643.55 | ||
| 2001-12-31 | 2002-02-27 | $197000 | -$2,408.01 | ||
| 2001-09-30 | 2001-11-28 | $197000 | -$1,497.90 | ||
| 2001-06-30 | 2001-06-30 | $262000 | -$1,407.88 | ||
| 2001-03-31 | 2001-03-31 | $456000 | -$1,243.50 | ||
| 2000-09-30 | 2000-09-30 | $538000 | -$1,393.73 | ||
| 2000-06-30 | 2000-06-30 | $N/A | -$1,343.51 | ||
| 2000-03-31 | 2000-03-31 | $19000 | -$1,462.02 | ||
| 1999-09-30 | 1999-09-30 | -$1,081.00 | |||
| 1999-06-30 | 1999-06-30 | -$2,154.30 | |||
| 1999-03-31 | 1999-03-31 | -$4,529.70 | |||
| 1998-09-30 | 1998-09-30 | -$3,534.49 | |||
| 1998-06-30 | 1998-06-30 | -$39,552.03 | |||
| 1998-03-31 | 1998-03-31 | -$8,740.01 |
Windtree Therapeutics, Inc (WINT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 3.46 million | 2.14 million | 3.79 million |
| Income Before Tax | N/A | N/A | -6.53 million | -7.38 million | -7.13 million |
| Selling General Administrative | N/A | N/A | 3.24 million | 2.41 million | 3.4 million |
| Gross Profit | N/A | N/A | N/A | N/A | -3.79 million |
| Ebit | N/A | N/A | -6.45 million | -7.24 million | -6.68 million |
| Operating Income | N/A | N/A | -6.7 million | -4.55 million | -7.19 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | 3.79 million |
| Total Other Income Expense Net | N/A | N/A | 124000 | -2.71 million | 141000 |
| Net Income From Continuing Operations | N/A | N/A | -6.53 million | -7.38 million | -7.13 million |
| Net Income Applicable to Common Shares | -9.02 million | -9.56 million | N/A | -7.38 million | -7.13 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -15000 | N/A | N/A | -62000 | 2.6 million |
| Change to Liabilities | N/A | -178000 | N/A | 345000 | -117000 |
| Total Cash Flow from Investing Activities | N/A | -12000 | N/A | -62000 | 2.6 million |
| Net Borrowings | N/A | N/A | N/A | -243000 | -346000 |
| Total Cash Flow from Financial Activities | -1.14 million | N/A | -199000 | 22.74 million | -346000 |
| Change to Operating Activities | N/A | -199000 | N/A | -1.97 million | 1.12 million |
| Change in Cash | -9.16 million | N/A | -5.78 million | 18.14 million | -1.69 million |
| Total Cash from Operating Activities | -8.26 million | -7.04 million | -5.48 million | -5.46 million | -3.82 million |
| Depreciation | 41000 | N/A | 42000 | -724000 | 344000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | 1000000 | N/A | N/A | N/A |
| Change to Net Income | N/A | 2.86 million | N/A | 4.22 million | 1.93 million |
| Capital Expenditures | 15000 | N/A | N/A | 62000 | 97000 |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 42.9 million | 44.04 million | 47.56 million |
| Total Stockholder Equity | N/A | N/A | 70.09 million | 74.94 million | 53.07 million |
| Other Current Liabilities | N/A | N/A | N/A | N/A | 1.87 million |
| Total Assets | N/A | N/A | 112.99 million | 118.98 million | 100.63 million |
| Common Stock | 17000 | 17000 | N/A | 41000 | 32000 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -710.23 million | -701.21 million | -691.66 million | -685.12 million | -677.75 million |
| Other Liabilities | 18.77 million | 17.13 million | N/A | 15.82 million | 15.33 million |
| Other Assets | 154000 | 154000 | N/A | 154000 | 154000 |
| Cash | N/A | N/A | 16.8 million | 22.58 million | 4.44 million |
| Total Current Liabilities | 6.31 million | N/A | 6.94 million | 7.82 million | 16.28 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 1.56 million | 1.76 million | N/A | 2.19 million | 2.44 million |
| Total Current Assets | 24.05 million | N/A | 18.1 million | 23.86 million | 5.26 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -17.05 million | -9.32 million | N/A | -17.84 million | -39.7 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | 4.55 million | 4.61 million | 15 million |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 726000 | N/A | 1.4 million | 1.71 million | 607000 |
Windtree Therapeutics, Inc (WINT) Chart:
Windtree Therapeutics, Inc (WINT) News:
Below you will find a list of latest news for Windtree Therapeutics, Inc (WINT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Windtree Therapeutics, Inc (WINT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest WINT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:41 PM EST | 1 | $0.4228 |
| Jun 13, 2022 7:41 PM EST | 10 | $0.4228 |
Windtree Therapeutics, Inc (WINT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920012549/0001437749-20-012549-index.htm |
| 2019-07-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/946486/000000000019010760/0000000000-19-010760-index.htm |
| 2019-07-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/946486/000000000019011271/0000000000-19-011271-index.htm |
| 2020-01-27 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/946486/000000000020000684/0000000000-20-000684-index.htm |
| 2020-09-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/946486/000000000020008945/0000000000-20-008945-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000121390019025800/0001213900-19-025800-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000121390019025802/0001213900-19-025802-index.htm |
| 2019-12-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/946486/000121390019026641/0001213900-19-026641-index.htm |
| 2019-12-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/946486/000121390019026643/0001213900-19-026643-index.htm |
| 2020-05-19 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/946486/000135445720000197/0001354457-20-000197-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774919013409/0001437749-19-013409-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774919013410/0001437749-19-013410-index.htm |
| 2019-07-17 | PRER14C | Information statements | https://www.sec.gov/Archives/edgar/data/946486/000143774919014168/0001437749-19-014168-index.htm |
| 2019-07-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/946486/000143774919014170/0001437749-19-014170-index.htm |
| 2019-07-18 | DEF 14C | Other definitive information statements | https://www.sec.gov/Archives/edgar/data/946486/000143774919014234/0001437749-19-014234-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774919016810/0001437749-19-016810-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/946486/000143774919016856/0001437749-19-016856-index.htm |
| 2019-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774919020664/0001437749-19-020664-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774919020750/0001437749-19-020750-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/946486/000143774919022959/0001437749-19-022959-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774919024091/0001437749-19-024091-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774919024141/0001437749-19-024141-index.htm |
| 2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774919024229/0001437749-19-024229-index.htm |
| 2019-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774919025048/0001437749-19-025048-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920000169/0001437749-20-000169-index.htm |
| 2020-01-21 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/946486/000143774920000849/0001437749-20-000849-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920000944/0001437749-20-000944-index.htm |
| 2020-01-27 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/946486/000143774920001187/0001437749-20-001187-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920001189/0001437749-20-001189-index.htm |
| 2020-01-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/946486/000143774920001294/0001437749-20-001294-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920001792/0001437749-20-001792-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920002069/0001437749-20-002069-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920002448/0001437749-20-002448-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920003165/0001437749-20-003165-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920005051/0001437749-20-005051-index.htm |
| 2020-03-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920005692/0001437749-20-005692-index.htm |
| 2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920005816/0001437749-20-005816-index.htm |
| 2020-03-30 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/946486/000143774920006529/0001437749-20-006529-index.htm |
| 2020-04-03 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/946486/000143774920006970/0001437749-20-006970-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920007030/0001437749-20-007030-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920008446/0001437749-20-008446-index.htm |
| 2020-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920008867/0001437749-20-008867-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920009006/0001437749-20-009006-index.htm |
| 2020-05-06 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/946486/000143774920009626/0001437749-20-009626-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920009712/0001437749-20-009712-index.htm |
| 2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/946486/000143774920010612/0001437749-20-010612-index.htm |
| 2020-05-14 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/946486/000143774920010653/0001437749-20-010653-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920010675/0001437749-20-010675-index.htm |
| 2020-05-15 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/946486/000143774920010889/0001437749-20-010889-index.htm |
| 2020-05-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/946486/000143774920011051/0001437749-20-011051-index.htm |
| 2020-05-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/946486/000143774920011052/0001437749-20-011052-index.htm |
| 2020-05-19 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011216/0001437749-20-011216-index.htm |
| 2020-05-21 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/946486/000143774920011490/0001437749-20-011490-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920011677/0001437749-20-011677-index.htm |
| 2020-05-27 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011861/0001437749-20-011861-index.htm |
| 2020-05-27 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011862/0001437749-20-011862-index.htm |
| 2020-05-27 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011863/0001437749-20-011863-index.htm |
| 2020-05-27 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011864/0001437749-20-011864-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011866/0001437749-20-011866-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011868/0001437749-20-011868-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011869/0001437749-20-011869-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011870/0001437749-20-011870-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011871/0001437749-20-011871-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011872/0001437749-20-011872-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011874/0001437749-20-011874-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011877/0001437749-20-011877-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011878/0001437749-20-011878-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920011879/0001437749-20-011879-index.htm |
| 2020-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920012393/0001437749-20-012393-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920012549/0001437749-20-012549-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920015187/0001437749-20-015187-index.htm |
| 2020-07-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920015548/0001437749-20-015548-index.htm |
| 2020-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920015549/0001437749-20-015549-index.htm |
| 2020-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920015621/0001437749-20-015621-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/946486/000143774920017885/0001437749-20-017885-index.htm |
| 2020-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920017886/0001437749-20-017886-index.htm |
| 2020-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920018484/0001437749-20-018484-index.htm |
| 2020-09-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/946486/000143774920019842/0001437749-20-019842-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920019844/0001437749-20-019844-index.htm |
| 2020-09-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/946486/000143774920020177/0001437749-20-020177-index.htm |
| 2020-09-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/946486/000143774920020334/0001437749-20-020334-index.htm |
| 2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920020386/0001437749-20-020386-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/946486/000143774920020552/0001437749-20-020552-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920020955/0001437749-20-020955-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920020956/0001437749-20-020956-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920020957/0001437749-20-020957-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920021001/0001437749-20-021001-index.htm |
| 2020-10-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920021048/0001437749-20-021048-index.htm |
| 2020-10-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920021655/0001437749-20-021655-index.htm |
| 2020-10-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920021666/0001437749-20-021666-index.htm |
| 2020-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/946486/000143774920021886/0001437749-20-021886-index.htm |
| 2019-12-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/946486/000156761919023441/0001567619-19-023441-index.htm |
| 2020-01-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/946486/999999999520000187/9999999995-20-000187-index.htm |
| 2020-05-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/946486/999999999520001197/9999999995-20-001197-index.htm |
| 2020-09-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/946486/999999999520002616/9999999995-20-002616-index.htm |
Windtree Therapeutics, Inc (WINT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Windtree Therapeutics, Inc (WINT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 7356%Institutional Ownership: 435%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-07 | John P. Hamill | SVP & CFO | Buy | 1,000.00 | 5.27 | 5,270.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920020957/0001437749-20-020957-index.htm |
| 2020-05-22 | Steven Simonson | SVP, Chief Medical Officer | Buy | 517.00 | 7.25 | 3,748.25 | 10,802.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011877/0001437749-20-011877-index.htm |
| 2020-05-22 | Mary B Esq Templeton | SVP, Gen Counsel & Corp Sec | Buy | 1,103.00 | 7.25 | 7,996.75 | 1,134.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011879/0001437749-20-011879-index.htm |
| 2019-12-06 | Pharmaceutical Holdings Ltd Lee's | 10% Share Holder | Buy | 1,655,629.00 | 3.02 | 4,999,999.58 | 14,450,599.00 | https://www.sec.gov/Archives/edgar/data/946486/000121390019025800/0001213900-19-025800-index.htm |
| 2020-06-04 | James Huang | Director | Buy | 12,200.00 | 7.32 | 89,332.06 | 20,200.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920012549/0001437749-20-012549-index.htm |
| 2019-12-31 | James Huang | Director | Buy | 15,442.00 | 4.05 | 62,524.66 | 20,442.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920000169/0001437749-20-000169-index.htm |
| 2020-01-16 | James Huang | Director | Buy | 58.00 | 4.20 | 243.60 | 20,500.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920000944/0001437749-20-000944-index.htm |
| 2020-05-22 | Brian D Schreiber | Director | Buy | 2,069.00 | 7.25 | 15,000.25 | 2,069.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011872/0001437749-20-011872-index.htm |
| 2020-05-22 | Daniel E. Geffken | Director | Buy | 2,069.00 | 7.25 | 15,000.25 | 2,069.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011866/0001437749-20-011866-index.htm |
| 2020-10-23 | James Huang | Director | Buy | 1,000.00 | 6.67 | 6,666.00 | 21,000.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920021666/0001437749-20-021666-index.htm |
| 2019-12-06 | James Huang | Director | Buy | 96,429.00 | 210,844.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774919024141/0001437749-19-024141-index.htm | ||
| 2020-01-17 | James Huang | Director | Buy | 2,000.00 | 4.18 | 8,365.80 | 22,500.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920000944/0001437749-20-000944-index.htm |
| 2020-02-07 | James Huang | Director | Buy | 500.00 | 4.05 | 2,025.00 | 23,000.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920002069/0001437749-20-002069-index.htm |
| 2020-05-22 | James Huang | Director | Buy | 275,862.00 | 7.25 | 1,999,999.50 | 2,336,853.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011868/0001437749-20-011868-index.htm |
| 2020-02-18 | James Huang | Director | Buy | 400.00 | 3.84 | 1,535.00 | 23,400.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920003165/0001437749-20-003165-index.htm |
| 2020-05-22 | Craig Fraser | President and CEO | Buy | 2,069.00 | 7.25 | 15,000.25 | 23,548.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011874/0001437749-20-011874-index.htm |
| 2020-10-07 | Craig Fraser | President and CEO | Buy | 250.00 | 5.17 | 1,292.50 | 23,798.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920020956/0001437749-20-020956-index.htm |
| 2020-10-09 | Craig Fraser | President and CEO | Buy | 250.00 | 5.83 | 1,456.25 | 24,048.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920021048/0001437749-20-021048-index.htm |
| 2020-10-28 | Craig Fraser | President and CEO | Buy | 250.00 | 6.56 | 1,639.88 | 24,298.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920021886/0001437749-20-021886-index.htm |
| 2019-12-06 | II Investments Ltd LPH | 10% Share Holder | Buy | 1,655,629.00 | 3.02 | 4,999,999.58 | 4,008,234.00 | https://www.sec.gov/Archives/edgar/data/946486/000121390019025802/0001213900-19-025802-index.htm |
| 2019-12-27 | James Huang | Director | Buy | 4,091.00 | 3.73 | 15,260.66 | 4,091.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774919025048/0001437749-19-025048-index.htm |
| 2020-10-08 | Eric Curtis | SVP & COO | Buy | 500.00 | 5.27 | 2,635.00 | 500.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920020955/0001437749-20-020955-index.htm |
| 2019-12-30 | James Huang | Director | Buy | 909.00 | 3.81 | 3,463.29 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774919025048/0001437749-19-025048-index.htm |
| 2019-12-06 | James Huang | Director | Buy | 1,655,629.00 | 3.02 | 4,999,999.58 | 6,182,974.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774919024141/0001437749-19-024141-index.htm |
| 2020-02-03 | Craig Fraser | President and CEO | Buy | 100.00 | 4.20 | 420.00 | 62,590.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920001792/0001437749-20-001792-index.htm |
| 2020-02-04 | Craig Fraser | President and CEO | Buy | 500.00 | 4.24 | 2,120.00 | 63,090.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920001792/0001437749-20-001792-index.htm |
| 2020-02-10 | Craig Fraser | President and CEO | Buy | 250.00 | 4.10 | 1,025.00 | 63,340.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920002448/0001437749-20-002448-index.htm |
| 2020-02-11 | Craig Fraser | President and CEO | Buy | 250.00 | 4.10 | 1,025.00 | 63,590.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920002448/0001437749-20-002448-index.htm |
| 2020-05-22 | Mahady M Joseph | Director | Buy | 2,069.00 | 7.25 | 15,000.25 | 7,455.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011870/0001437749-20-011870-index.htm |
| 2020-05-22 | John R Leone | Director | Buy | 2,069.00 | 7.25 | 15,000.25 | 7,473.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011869/0001437749-20-011869-index.htm |
| 2020-06-03 | James Huang | Director | Buy | 200.00 | 7.42 | 1,483.98 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920012549/0001437749-20-012549-index.htm |
| 2020-05-22 | BRUCE PEACOCK | Director | Buy | 3,500.00 | 7.25 | 25,375.00 | 8,886.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011871/0001437749-20-011871-index.htm |
| 2020-05-22 | John A Tattory | SVP & CFO | Buy | 449.00 | 7.25 | 3,255.25 | 9,280.00 | https://www.sec.gov/Archives/edgar/data/946486/000143774920011878/0001437749-20-011878-index.htm |